Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have failed or are intolerant to anti TNFs
hsCRP greater or equal to 5.0 mg/L
Ulcerations demonstrated by colonoscopy as defined by SES CD assessment performed within 8 weeks of study entry (screening) and able to retrospectively complete the SES-CD or colonoscopy performed during screening
You may not be if
Pregnant or breastfeeding women
Crohn's Disease with active fistulae or abscess
History of diverticulitis or symptomatic diverticulosis
Abnormality in hematology or chemistry profiles at screening
Clareo Health | A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
